Kodiak Sciences Statistics
 Total Valuation
 Kodiak Sciences has a market cap or net worth of $978.18 million. The enterprise value is $939.23 million.
   Important Dates
 The next estimated earnings date is Thursday, November 13, 2025, after market close.
 | Earnings Date  | Nov 13, 2025 | 
| Ex-Dividend Date  | n/a | 
  Share Statistics
 Kodiak Sciences has 52.70 million shares outstanding. The number of shares has increased by 0.38% in one year.
 | Current Share Class  | 52.70M | 
| Shares Outstanding  | 52.70M | 
| Shares Change (YoY)  | +0.38% | 
| Shares Change (QoQ)  | +0.06% | 
| Owned by Insiders (%)  | 5.53% | 
| Owned by Institutions (%)  | 45.95% | 
| Float  | 29.51M | 
   Valuation Ratios
  | PE Ratio  | n/a | 
| Forward PE  | n/a | 
| PS Ratio  | n/a | 
| Forward PS  | n/a | 
| PB Ratio  | 13.92 | 
| P/TBV Ratio  | 13.92 | 
| P/FCF Ratio  | n/a | 
| P/OCF Ratio  | n/a | 
| PEG Ratio  | n/a | 
 Financial Ratio History  Enterprise Valuation
  | EV / Earnings  | n/a | 
| EV / Sales  | n/a | 
| EV / EBITDA  | n/a | 
| EV / EBIT  | n/a | 
| EV / FCF  | n/a | 
  Financial Position
 The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.93.
 | Current Ratio  | 3.48 | 
| Quick Ratio  | 3.36 | 
| Debt / Equity  | 0.93 | 
| Debt / EBITDA  | n/a | 
| Debt / FCF  | n/a | 
| Interest Coverage  | n/a | 
   Financial Efficiency
 Return on equity (ROE) is -140.33% and return on invested capital (ROIC) is -60.89%.
 | Return on Equity (ROE)  | -140.33% | 
| Return on Assets (ROA)  | -39.38% | 
| Return on Invested Capital (ROIC)  | -60.89% | 
| Return on Capital Employed (ROCE)  | -91.88% | 
| Revenue Per Employee  | n/a | 
| Profits Per Employee  | -$1.83M | 
| Employee Count | 109 | 
| Asset Turnover  | n/a | 
| Inventory Turnover  | n/a | 
  Taxes
  | Income Tax  | n/a | 
| Effective Tax Rate  | n/a | 
  Stock Price Statistics
 The stock price has increased by +383.33% in the last 52 weeks. The beta is 2.71, so Kodiak Sciences's price volatility has been higher than the market average.
 | Beta (5Y)  | 2.71 | 
| 52-Week Price Change  | +383.33% | 
| 50-Day Moving Average  | 13.46 | 
| 200-Day Moving Average  | 6.99 | 
| Relative Strength Index (RSI)  | 58.16 | 
| Average Volume (20 Days)  | 975,090 | 
  Short Selling Information
 The latest short interest is 3.80 million, so 7.20% of the outstanding shares have been sold short.
 | Short Interest  | 3.80M | 
| Short Previous Month  | 3.81M | 
| Short % of Shares Out  | 7.20% | 
| Short % of Float  | 12.86% | 
| Short Ratio (days to cover)  | 3.54 | 
  Income Statement
  | Revenue  | n/a | 
| Gross Profit  | n/a | 
| Operating Income  | -207.39M | 
| Pretax Income  | -199.83M | 
| Net Income  | -199.83M | 
| EBITDA  | -188.89M | 
| EBIT  | -207.39M | 
| Earnings Per Share (EPS)  | -$3.79 | 
 Full Income Statement  Balance Sheet
 The company has $104.17 million in cash and $65.21 million in debt, giving a net cash position of $38.95 million or $0.74 per share.
 | Cash & Cash Equivalents  | 104.17M | 
| Total Debt  | 65.21M | 
| Net Cash  | 38.95M | 
| Net Cash Per Share  | $0.74 | 
| Equity (Book Value)  | 70.29M | 
| Book Value Per Share  | 1.33 | 
| Working Capital  | 76.91M | 
 Full Balance Sheet  Cash Flow
 In the last 12 months, operating cash flow was -$114.98 million and capital expenditures -$732,000, giving a free cash flow of -$115.71 million.
 | Operating Cash Flow  | -114.98M | 
| Capital Expenditures  | -732,000 | 
| Free Cash Flow  | -115.71M | 
| FCF Per Share  | -$2.20 | 
 Full Cash Flow Statement  Margins
  | Gross Margin  | n/a | 
| Operating Margin  | n/a | 
| Pretax Margin  | n/a | 
| Profit Margin  | n/a | 
| EBITDA Margin  | n/a | 
| EBIT Margin  | n/a | 
| FCF Margin  | n/a | 
  Dividends & Yields
 Kodiak Sciences does not appear to pay any dividends at this time.
 | Dividend Per Share  | n/a | 
| Dividend Yield  | n/a | 
| Dividend Growth (YoY)  | n/a | 
| Years of Dividend Growth  | n/a | 
| Payout Ratio  | n/a | 
| Buyback Yield  | -0.38% | 
| Shareholder Yield  | -0.38% | 
| Earnings Yield  | -20.43% | 
| FCF Yield  | -11.83% | 
    Analyst Forecast
 The average price target for Kodiak Sciences is $19.29, which is 3.93% higher than the current price. The consensus rating is "Buy".
 | Price Target  | $19.29 | 
| Price Target Difference  | 3.93% | 
| Analyst Consensus  | Buy | 
| Analyst Count  | 7 | 
| Revenue Growth Forecast (5Y)  | n/a | 
| EPS Growth Forecast (5Y)  | -32.79% | 
 Stock Forecasts  Fair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value  | n/a | 
| Lynch Upside  | n/a | 
| Graham Number  | n/a | 
| Graham Upside  | n/a | 
  Stock Splits
 This stock does not have any record of stock splits.
 | Last Split Date  | n/a | 
| Split Type  | n/a | 
| Split Ratio  | n/a | 
  Scores
  | Altman Z-Score  | n/a | 
| Piotroski F-Score  | 1 |